"10.1371_journal.pone.0125954","plos one","2015-05-11T00:00:00Z","Gloria Omosa-Manyonyi; Juliet Mpendo; Eugene Ruzagira; William Kilembe; Elwyn Chomba; François Roman; Patricia Bourguignon; Marguerite Koutsoukos; Alix Collard; Gerald Voss; Dagna Laufer; Gwynn Stevens; Peter Hayes; Lorna Clark; Emmanuel Cormier; Len Dally; Burc Barin; Jim Ackland; Kristen Syvertsen; Devika Zachariah; Kamaal Anas; Eddy Sayeed; Angela Lombardo; Jill Gilmour; Josephine Cox; Patricia Fast; Frances Priddy","Kenya AIDS Vaccine Initiative, University of Nairobi, Nairobi, Kenya; Uganda Virus Research Institute-IAVI, Entebbe, Uganda; Medical Research Council (MRC)/Uganda Virus Research Institute (UVRI), Uganda, Research Unit on AIDS, Entebbe, Uganda; Zambia Emory HIV Research Program, Lusaka, Zambia; University Teaching Hospital, Lusaka, Zambia; GlaxoSmithKline Vaccines, Rixensart, Belgium; International AIDS Vaccine Initiative (IAVI), New York, NY, United States of America; IAVI, Johannesburg, South Africa; IAVI, Human Immunology Laboratory, London, United Kingdom; EMMES Corporation, Rockville, MD, United States of America; Global BioSolutions, Melbourne, Australia","Conceived and designed the experiments: PF FP AL JC PB JG MK GV FR ES AC JA. Performed the experiments: GO-M JM ER WK E. Chomba DL FP GS PH LC E. Cormier. Analyzed the data: JC LD BB AC PB MK E. Cormier PH AL. Contributed reagents/materials/analysis tools: ES KS DZ KA JA. Wrote the paper: JC PF FP PB AL MK AC LD BB GO-M JM.","Dagna Laufer, Gwynn Stevens, Emmanuel Cormier, Kristen Syvertsen, Devika Zachariah, Kamaal Anas, Eddy Sayeed, Angela Lombardo, Jill Gilmour, Josephine Cox, Patricia Fast and Frances Priddy are or were employees of IAVI at the time of the study. IAVI has development rights for the Ad35-GRIN product. Patent name HIV-1 Clade A Consensus Sequences, Antigens and Transgenes. Patent umber US 8,119,144 B2. UPDATED PATENT INFO; François Roman, Patricia Bourguignon and Alix Collard are employees of GSK group of companies, which owns the rights to the F4 and AS01 products and whose company provided funding towards this study. Marguerite Koutsoukos and Gerald Voss are employees of the GSK group of companies. They both own shares in GSK and are listed as inventors on patents owned by GSK. Patent name for AS01: Compositions comprising QS21 and 3D-MPL. Patent numbers US W094/000153 (US5750110, US7147862). Patent name for F4: F4 constructs. Patent number WO06/013106 (US7612173). Jim Ackland is an employee of Global BioSolutions. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2015","05","Gloria Omosa-Manyonyi","GOM",27,TRUE,12,5,7,11,TRUE,FALSE,TRUE,4,"11;12;13;14",TRUE
